RIPK3 and metastatic neoplasm: Interestingly, RIPK3 levels varied considerably in cells from the metastatic osteosarcomas: 1029LV and 493L expressed robust levels, 494L expressed less, and none was detected in lysates of cells from the metastatic tumors 98L, 147L or 148L (Figure 10).